1NIHR Nottingham Biomedical Research Centre, Ropewalk House, Nottingham, United Kingdom
2Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom
3Manchester Centre for Audiology and Deafness (ManCAD), School of Health Sciences, University of Manchester, Manchester, United Kingdom
4Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
5Cincinnati Children’s Hospital Medical Center and Department of Otolaryngology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
6Nottingham University Hospitals NHS Trust, Queens Medical Centre, Nottingham, United Kingdom.
Received April 2, 2019; accepted August 30, 2020; published online ahead of print November 16, 2020.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and text of this article on the journal’s Web site (www.ear-hearing.com).
R.H.P. and P.T.K. conceived the study and wrote the manuscript. R.H.P. analyzed the data. All authors contributed to study design and critically revised the article.
This research was supported by the National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre (BRC) for R.H.P., P.T.K., and M.E.J. and the NIHR Manchester BRC for P.D., D.R.M., and K.J.M. R.H.P. received a personal grant from the NIHR Academy to support collaboration with the Manchester BRC during the conduct of the study. D.R.M. declares grants from the Medical Research Council (UK), the NIHR, Cincinnati Children’s Hospital, and personal fees from University of Manchester during the conduct of the study; P.T.K. declares grants from the NIHR during the conduct of the study. D.R.M. declares personal fees and nonfinancial support from Otonomy Inc. and personal fees, nonfinancial support, and other support from hearX Group outside the submitted work; P.T.K. declares grants from Cochlear Europe Ltd., nonfinancial support from Phonak UK, personal fees from Phonak Ltd., and other support from Cochlear Europe Ltd. outside the submitted work. R.H.P. declares a travel grant from Oticon Medical.
Address for correspondence: Robert H. Pierzycki, NIHR Nottingham Biomedical Research Centre, Ropewalk House, 113 The Ropewalk, Nottingham NG1 5DU, United Kingdom. E-mail: [email protected]
